Phoenix Group mandates for euros as pharma sector hunts cash
German pharmaceutical company, Phoenix Pharmahandel (Phoenix Group), held investor calls on Monday after mandating banks for a sub-benchmark sized offering in euros. The deal is the latest stab at funding by a pharmaceutical company — a sector which has lured greater numbers of investors thanks to the coronavirus pandemic.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: